Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.1150
-0.0350 (-23.33%)
Oct 20, 2026, 5:35 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €18.29 thousand as of October 20, 2026. It is the 51,514th most valuable company in the world and the 692nd biggest in France. Its market cap has decreased by 53.28% in one year.
Market Cap
18.29K
Enterprise Value
-15.94K
Revenue
401.01K
Global Rank
Country Rank
#692 France
PE Ratio
n/a
ChartMarket Cap Chart
Since June 2, 2025, Neovacs's market cap has decreased from 600.00K to 18.29K, a decrease of -96.95%. That is a compound annual growth rate of -91.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 18.29K | 347.46% |
| Dec 31, 2025 | 4.09K | -99.32% |
| Jun 2, 2025 | 600.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biophytis | 11.76M |
| Aton | 10.77M |
| TME Pharma | 10.29M |
| Aelis Farma | 10.05M |
| Poxel | 9.76M |
| Advicenne | 9.46M |
| NFL Biosciences | 7.22M |
| Oncodesign Precision Medicine Société anonyme | 5.90M |